697 related articles for article (PubMed ID: 26627939)
1. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
[TBL] [Abstract][Full Text] [Related]
2. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
Waragai M; Moriya M; Nojo T
J Alzheimers Dis; 2017; 60(4):1411-1427. PubMed ID: 28968236
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
Targosz-Gajniak MG; Siuda JS; Wicher MM; Banasik TJ; Bujak MA; Augusciak-Duma AM; Opala G
J Neurol Sci; 2013 Dec; 335(1-2):58-63. PubMed ID: 24035276
[TBL] [Abstract][Full Text] [Related]
4. Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease.
Pagonabarraga J; Gómez-Ansón B; Rotger R; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A; Delfino M; Ruscalleda J; Kulisevsky J
Dement Geriatr Cogn Disord; 2012; 34(5-6):312-8. PubMed ID: 23208306
[TBL] [Abstract][Full Text] [Related]
5. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
7. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
8. Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment.
Nie K; Zhang Y; Huang B; Wang L; Zhao J; Huang Z; Gan R; Wang L
Parkinsonism Relat Disord; 2013 Mar; 19(3):329-34. PubMed ID: 23238068
[TBL] [Abstract][Full Text] [Related]
9. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
10. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of posterior cingulate metabolism in patients with mild cognitive impairment due to Parkinson's disease or Alzheimer's disease.
Huang M; Yu H; Cai X; Zhang Y; Pu W; Gao B
Sci Rep; 2023 Aug; 13(1):14241. PubMed ID: 37648724
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance spectroscopy in mild cognitive impairment: systematic review and meta-analysis.
Tumati S; Martens S; Aleman A
Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 2):2571-86. PubMed ID: 23969177
[TBL] [Abstract][Full Text] [Related]
13. Proton magnetic resonance spectroscopy in mild cognitive impairment and Alzheimer's disease: a preliminary study.
Suriyajakryuththana W; Tuntiyatorn L; Teepprasarn N; Sukying C
J Med Assoc Thai; 2014 Apr; 97(4):407-14. PubMed ID: 24964683
[TBL] [Abstract][Full Text] [Related]
14. Detection and application of neurochemical profile by multiple regional
Guan J; Rong Y; Wen Y; Wu H; Qin H; Zhang Q; Chen W
Brain Behav; 2017 Sep; 7(9):e00792. PubMed ID: 28948086
[TBL] [Abstract][Full Text] [Related]
15. Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia.
Griffith HR; den Hollander JA; Okonkwo OC; O'Brien T; Watts RL; Marson DC
Alzheimers Dement; 2008 Nov; 4(6):421-7. PubMed ID: 19012867
[TBL] [Abstract][Full Text] [Related]
16. Age-related differences in metabolites in the posterior cingulate cortex and hippocampus of normal ageing brain: a 1H-MRS study.
Reyngoudt H; Claeys T; Vlerick L; Verleden S; Acou M; Deblaere K; De Deene Y; Audenaert K; Goethals I; Achten E
Eur J Radiol; 2012 Mar; 81(3):e223-31. PubMed ID: 21345628
[TBL] [Abstract][Full Text] [Related]
17. Brain N-acetylaspartate is reduced in Parkinson disease with dementia.
Griffith HR; den Hollander JA; Okonkwo OC; O'Brien T; Watts RL; Marson DC
Alzheimer Dis Assoc Disord; 2008; 22(1):54-60. PubMed ID: 18317247
[TBL] [Abstract][Full Text] [Related]
18. (1)H-MRS asymmetry changes in the anterior and posterior cingulate gyrus in patients with mild cognitive impairment and mild Alzheimer's disease.
Guo Z; Liu X; Hou H; Wei F; Chen X; Shen Y; Chen W
Compr Psychiatry; 2016 Aug; 69():179-85. PubMed ID: 27423359
[TBL] [Abstract][Full Text] [Related]
19. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.
Kantarci K; Jack CR; Xu YC; Campeau NG; O'Brien PC; Smith GE; Ivnik RJ; Boeve BF; Kokmen E; Tangalos EG; Petersen RC
Neurology; 2000 Jul; 55(2):210-7. PubMed ID: 10908893
[TBL] [Abstract][Full Text] [Related]
20. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
Foy CM; Daly EM; Glover A; O'Gorman R; Simmons A; Murphy DG; Lovestone S
Brain Topogr; 2011 Oct; 24(3-4):316-22. PubMed ID: 21298332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]